Search

Your search keyword '"Saito, K."' showing total 2,927 results

Search Constraints

Start Over You searched for: Author "Saito, K." Remove constraint Author: "Saito, K." Database Unpaywall Remove constraint Database: Unpaywall
2,927 results on '"Saito, K."'

Search Results

4. Real-world outcomes of first-line systematic treatment in advanced upper urinary tract urothelial carcinoma patients with renal impairment: YUSHIMA-04 study

5. Outcomes of partial and radical nephrectomy in patients with pathological T3a upstaging of clinical T1 renal cell carcinoma: an analysis from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort

6. Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: analysis of the phase 3 randomized CLEAR study

8. Low muscle strength as a predictor of incident pneumonia in older patients with heart failure: sub-analysis of fragile-hf

9. Prognostic impact of a novel risk score for transcatheter edge-to-edge repair in patients with heart failure: sub-analysis of FRAGILE-HF

14. ICRF plasma production at hydrogen minority regime in LHD

31. Impact of preoperative C-reactive protein level on oncological outcomes after nephrectomy in patients with high-risk renal cell carcinoma: An analysis from the International Marker Consortium for Renal Cancer (INMARC) cohort

32. Test and extraction methods for the QC parameters of silicon strip sensors for ATLAS upgrade tracker

33. Overview of Fragment Separator Superconducting Magnets in the Facility for Rare Isotope Beams

38. 142P The predictive biomarker for immune-related adverse events (irAEs) in patients with metastatic renal cell carcinoma treated with the combination therapy of nivolumab plus ipilimumab: Musashino study-irAE

39. 144P Association between immune-related adverse events and survival in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab

40. Pre-production results from ATLAS ITk Strip Sensors Quality Assurance Testchip

41. 139MO Prognostic significance of the mechanism of inflammatory markers in advanced renal cell carcinoma patients treated with nivolumab plus ipilimumab

43. P.103 Onasemnogene abeparvovec (OA) treatment outcomes by patient weight at infusion: Initial findings from the RESTORE registry

45. P.114 SUNFISH parts 1 and 2: 3-year efficacy and safety of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)

46. P.104 Treatments and outcomes for patients with spinal muscular atrophy (SMA) type 2: Findings from RESTORE registry

47. P.105 Safety and effectiveness of onasemnogene abeparvovec (OA) alone or with other disease-modifying therapies (DMTs): Findings from RESTORE

Catalog

Books, media, physical & digital resources